Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting


N/A
18 Years
N/A
Not Enrolling
Both
Gastrointestinal Stromal Tumors

Thank you

Trial Information

Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting


Inclusion Criteria:



- Patients diagnosed with GIST based on ICD-9 code from January 2005 to present will be
eligible. This will include current active patients as well as patients who have
expired and have medical chart available.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Principal Investigator

Jeffrey F Patton, M.D.

Investigator Role:

Study Chair

Investigator Affiliation:

Sarah Cannon Research Institute

Authority:

United States: Institutional Review Board

Study ID:

SCRI OUTCOMES 01

NCT ID:

NCT00877045

Start Date:

January 2008

Completion Date:

February 2009

Related Keywords:

  • Gastrointestinal Stromal Tumors
  • Gastrointestinal Stromal Tumors
  • GIST
  • tyrosine kinase inhibitors
  • Imatinib
  • Gleevec
  • Suntinib
  • Sutent
  • Gastrointestinal Stromal Tumors

Name

Location
Georgia Cancer Specialists Decatur, Georgia  30033
Florida Cancer Specialists Fort Myers, Florida  33901
Virginia Cancer Institute Richmond, Virginia  23230
Tennessee Oncology, PLLC Clarksville, Tennessee  37043
Chattanooga Oncology Hematology Associates Chattanooga, Tennessee  37404